Company Name
Aurisco Pharmaceutical Co., Ltd.
Year of Establishment
1998
Company Introduction
Established in 1998, Aurisco is an innovative pharmaceutical company engaged in research, manufacturing and marketing of specialty APIs, formulations as well as CMO service. With the registration address in Zhejiang Tiantai , the company has operation center in Shanghai and subsidiaries in USA, Portugal, Brazil,Yangzhou,Hangzhou and Tianjing. Aurisco has been deeply involved in the pharmaceutical industry for more than 20 years and commits itself to continuous technological innovation. Today the company is playing a leading role in China in the field of complex synthesis, synthetic biology, photochemistry etc. And has become a long-term partner of the well-known pharmaceutical companies worldwide. Complete quality system,sufficient production capaciy and globe sales network enable the company to provide high-quality products and efficient service to our customers around the world.
Main Competitive Advantages
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.aurisco.com
Milestone
2021.07.07 Shanghai Aurisco Biotechnology Co., ltd. was established.
2020 Listed on the Shanghai Stock Exchange on September 21
2019 Acquired APTI from Apotex, Established R&D center in Tianjin
2017 Established Aurisco Pharmaceutical (Joint Stock) Co., Ltd.
2015.08, Started to construct the 3rd factory(120,000 m2) in Yangzhou for Formulations & APIs
2013.11, Passed the inspection by USFDA in Tiantai factory
2013.04, Passed the GMP inspection by Germany Authority in Tiantai factory
2012.11, 10th Anniversary
2012.11, Joined Rx-360 and became the 1st Chinese pharmaceutical company in this organization
2011.05, Passed the GMP&EHS inspection by RX-360 in Tiantai factory
2009.02, Passed the inspection by UK MHRA in Tiantai factory
2008.10, Started to use manufacturing site (50,000 m2) in Yangzhou
2008.09, Achieved COS certificate in Tiantai factory
2008.07, Started to use 2nd manufacturing site (65,000 m2)
2008.05, Achieved cGMP in Tiantai factory
2006 Set up Yangzhou Facility primarily for fermentation research and production
2002 Operation Center in Shanghai was established
1998 Set up Aurisco